Newest Research on “IBS Treatment Market” – Forecast by Top Regions 2023-2028

Irritable bowel syndrome (IBS) is a common disorder that affects the digestive system. IBS is characterized by symptoms such as stomach cramps, bloating, diarrhea, and constipation, which impacts one’s everyday life. Although the cause of IBS is unknown, but few factors that cause IBS are severe infection, inflammation in the intestines, muscle contractions in the intestine, changes in bacteria in the gut, and abnormalities in the nerves.
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for IBS Treatment estimated at USD million in the year 2022, is projected to reach a revised size of USD million by 2028, growing at a CAGR of Percent during the forecast period 2022-2028.
Rising prevalence of gastrointestinal diseases and disorder, geriatric population, unhealthy diet, anxiety, depression, and changing lifestyle in Americas are the key drivers of the Americas IBS market. Moreover, strong clinical pipeline and government support is fuelling the market in this region. According to an updated report by the Anxiety and Depression Association of America, in 2017, the most common mental disorder was anxiety in the United States, affecting approximately 40 million adults over 18 years every year.

Major Product Types of IBS Treatment covered are:

  • IBS-D
  • IBS-C
  • IBS-M

    Major Applications of IBS Treatment covered are:

  • Hospitals
  • Clinics
  • Research Laboratories

    key players operating in the IBS Treatment market

  • Allergan (Ireland)
  • Sucampo Pharmaceuticals (U.S.)
  • Ironwood Pharmaceuticals (U.S.)
  • Astellas Pharma (Japan)
  • Bausch Health
  • Abbott Laboratories (U.S.)
  • Synergy Pharmaceuticals (U.S.)
  • Ardelyx (U.S.)
  • Nestle (Switzerland)
  • Sebela Pharmaceuticals (Ireland)
  • Probi (Sweden)
  • Alfasigma USA (Italy)
  • RedHill Biopharma (Israel)
  • AstraZeneca (U.K)
  • Ipsen (France)
  • Novartis (Switzerland)
  • Takeda Pharmaceutical Company (Japan)
  • Synthetic Biologics (U.S.)
  • Protagonist Therapeutics (U.S.)
  • Pfizer (U.S.)
  • Lexicon Pharmaceuticals (U.S.)
  • Innovate Biopharmaceuticals (U.S.)

    About Us:

    Market is changing rapidly with the ongoing expansion of the industry. Advancement in the technology has provided today’s businesses with multifaceted advantages resulting in daily economic shifts. Thus, it is very important for a company to comprehend the patterns of the market movements in order to strategize better. An efficient strategy offers the companies with a head start in planning and an edge over the competitors. Market Growth Reports is the credible source for gaining the market reports that will provide you with the lead your business needs.

    Contact Us:

    Market growth reports

    Phone : US +1 424 253 0946

                   UK +44 203 239 8187

    Email : [email protected]

    Web :

    For More Related Reports Click Here :

    From 2023 to 2028 Report on the Pipeline Pigging Services market

    Anti-Reflection Coatings Market : Global Strategic Business Report 2029

    Margarine and Shortening Market | Industry Forecast 2023 – 2029

    From 2023 to 2029 Report on the Unmanned Ground Vehicle (UGV) market

    Endovascular Therapy Devices Market | Forecast 2023 to 2029 |